|
WO2021072218A1
|
|
Method of treating immunotherapy non-responders with an autologous cell therapy
|
|
WO2021072044A1
|
|
Methods of treatment using a genetically modified autologous t-cell immunotherapy
|
|
US2021062248A1
|
|
Methods of performing guide-seq on primary human t cells
|
|
WO2020223478A1
|
|
Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapy
|
|
WO2020205759A1
|
|
Personalized neoantigen-specific adoptive cell therapies
|
|
WO2020167918A1
|
|
Compositions and methods for identification of antigen specific t cells
|
|
WO2020056173A1
|
|
Antigen specific tcr identification using single-cell sorting
|
|
AU2019248644A1
|
|
Peptide-MHC compacts
|
|
CA3081320A1
|
|
Primary cell gene editing
|
